ITNS (Itonis) Inventories, Raw Materials & Components: $0.00 Mil (As of Feb. 2008)


What is Itonis Inventories, Raw Materials & Components?

Itonis ITNS Inventories, Raw Materials & Components is $0.00 Mil as of Feb. 2008.

Itonis's inventories, raw materials & components for the quarter that ended in Feb. 2008 was $0.00 Mil.


Itonis Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Itonis's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Itonis Inventories, Raw Materials & Components Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Inventories, Raw Materials & Components
0.00 0.00 0.00

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Itonis Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.00 Mil mean?
Itonis (ITNS) has a Inventories, Raw Materials & Components of $0.00 Mil as of Feb. 2008. Raw materials are the components a company uses for its main products. View historical data on Itonis and its competitors.
Is Itonis' Inventories, Raw Materials & Components too high?
Itonis' current Inventories, Raw Materials & Components is $0.00 Mil.
How does Itonis' Inventories, Raw Materials & Components compare to FZMD and SNYR?
Itonis' Inventories, Raw Materials & Components of $0.00 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Distribution company?
A good Inventories, Raw Materials & Components depends on the Medical Distribution industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Itonis and its competitors. Itonis's current Inventories, Raw Materials & Components is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Itonis stock overvalued right now?
Itonis (ITNS) has a current Inventories, Raw Materials & Components of $0.00 Mil. The current Inventories, Raw Materials & Components is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Itonis (ITNS), the current Inventories, Raw Materials & Components is $0.00 Mil as of Feb. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Itonis Business Description

Address 25422 Trabuco Road, Suite 105-297, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.